Published in Rev Clin Esp on June 01, 1989
Organ procurement in Spain: impact of transplant coordination. Clin Transplant (1994) 3.70
European Society of Hypertension practice guidelines for home blood pressure monitoring. J Hum Hypertens (2010) 2.06
[Drug combinations: an alternative in the treatment of arterial hypertension]. Med Clin (Barc) (1995) 2.04
[Calcium antagonists and their impact on risk of coronary disease]. Med Clin (Barc) (1996) 2.03
Response to antihypertensive therapy in older patients with sustained and nonsustained systolic hypertension. Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Circulation (2000) 1.98
Control of hypertension in coronary heart disease. Int J Cardiol (2008) 1.93
Practice guidelines for primary care physicians: 2003 ESH/ESC hypertension guidelines. J Hypertens (2003) 1.93
FGF-10 is a chemotactic factor for distal epithelial buds during lung development. Dev Biol (1998) 1.78
Organ procurement and renal transplants in Spain: the impact of transplant coordination. Spanish National Transplant Organization (ONT) Nephrol Dial Transplant (1994) 1.54
Influence of obesity on the appearance of proteinuria and renal insufficiency after unilateral nephrectomy. Kidney Int (2000) 1.43
[Relationship between cardiovascular risk profile and anti-hypertensive drug use. GEDEC (Spanish group of cardiovascular studies]. Med Clin (Barc) (2000) 1.42
[Telemedicine and follow up of peritoneal dialysis patients]. Nefrologia (2006) 1.42
Acute renal failure after use of diesel fuel as shampoo. Arch Intern Med (1977) 1.40
Familial hypomagnesemia with hypercalciuria and nephrocalcinosis. Kidney Int (1995) 1.40
[Home self-measurements of blood pressure and relationship with diagnosis of hypertension and target organ damage: comparative study with ambulatory monitoring]. Med Clin (Barc) (2000) 1.39
How to handle renovascular hypertension. J Hypertens (2001) 1.39
[Opinion survey on renal donation from living donor]. Nefrologia (2005) 1.39
[Peritoneal transudates and low adenosine deaminase in tuberculous peritonitis]. Rev Clin Esp (1992) 1.38
[Nontraumatic rhabdomyolysis: its etiology and the predictive factors of acute kidney failure]. Med Clin (Barc) (1995) 1.38
Cholesterol levels in untreated Spanish hypertensive patients. The Compas Study Group, Spanish Hypertension Society. Blood Press (1999) 1.38
[Relationship between severity of essential arterial hypertension and the prevalence hyperuricemia]. Med Clin (Barc) (2001) 1.38
[Spanish contribution to the HOT (Hypertension Optimal Treatment) study. Final results. Spanish Investigators in the HOT study]. Med Clin (Barc) (1999) 1.37
Prognostic value of ambulatory blood pressure monitoring in refractory hypertension: a prospective study. Hypertension (1998) 1.32
Polymorphisms of renin-angiotensin genes among Nigerians, Jamaicans, and African Americans. Hypertension (1996) 1.27
Community-acquired pneumonia in patients with and without chronic obstructive pulmonary disease. J Infect (2009) 1.16
ACE, angiotensinogen and obesity: a potential pathway leading to hypertension. J Hum Hypertens (1997) 1.14
Uric acid as a cardiovascular risk factor in arterial hypertension. J Hypertens (1999) 1.12
Influence of cyclosporin, tacrolimus and rapamycin on renal function and arterial hypertension after renal transplantation. Nephrol Dial Transplant (2001) 1.08
The pharmacokinetics of a single dose of calcitriol administered subcutaneously in continuous ambulatory peritoneal dialysis patients. Perit Dial Int (1993) 1.07
Prevalence of hepatitis C antibodies (HCV) in a dialysis population at one center. Perit Dial Int (1992) 1.07
ESH-ESC guidelines for the management of hypertension. Herz (2006) 1.05
Peritoneal sodium mass removal in continuous ambulatory peritoneal dialysis and automated peritoneal dialysis: influence on blood pressure control. Am J Nephrol (2001) 1.01
Design and validation of a specialized training model for tissue bank personnel as a result of the European Quality System for Tissue Banking (EQSTB) project. Transplant Proc (2007) 0.98
Long-term beneficial effects of angiotensin-converting enzyme inhibition in patients with nephrotic proteinuria. Am J Kidney Dis (1992) 0.95
Determinants of urinary albumin excretion within the normal range in patients with type 2 diabetes: the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study. Diabetologia (2009) 0.95
Hormonal, renal, and metabolic alterations during hypertension induced by chronic inhibition of NO in rats. Am J Physiol (1994) 0.94
Membranous glomerulonephritis associated with hepatitis C virus infection in renal transplant patients. Transplantation (1997) 0.94
Effects of body-weight loss and captopril treatment on proteinuria associated with obesity. Nephron (1995) 0.93
Microalbuminuria in essential hypertension. Kidney Int Suppl (1998) 0.92
Idiopathic IgA nephropathy. Kidney Int (1984) 0.91
Renal vein thrombosis, nephrotic syndrome, and focal lupus glomerulonephritis. Br Med J (1978) 0.90
Nephrotic proteinuria without hypoalbuminemia: clinical characteristics and response to angiotensin-converting enzyme inhibition. Am J Kidney Dis (1991) 0.89
Clinical relevance of proteinuria and microalbuminuria. Curr Opin Nephrol Hypertens (1993) 0.89
Follow-up of renal function in treated and untreated older patients with isolated systolic hypertension. Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. J Hypertens (2001) 0.89
Squamous cell carcinoma of the renal pelvis associated with hypercalcemia and the presence of parathyroid hormone-like substances in the tumor. J Urol (1985) 0.88
Ischemic nephropathy: clinical characteristics and treatment. Am J Kidney Dis (2000) 0.88
Pressure natriuresis in nitric oxide-deficient hypertensive rats: effect of antihypertensive treatments. J Am Soc Nephrol (1999) 0.88
Converting enzyme inhibition in chronic renal failure. Am J Kidney Dis (1989) 0.88
Influence of a low sodium diet on the renal response to amino acid infusions in humans. Kidney Int (1987) 0.88
Acute worsening of renal function during episodes of macroscopic hematuria in IgA nephropathy. Kidney Int (1985) 0.87
Occult lead intoxication as a cause of hypertension and renal failure. Nephrol Dial Transplant (1996) 0.86
Partial deficit of hypoxanthine guanine phosphoribosyl transferase presenting as acute renal failure. Nephron (1987) 0.86
Calcium channel blockade and preservation of renal graft function in cyclosporine-treated recipients: a prospective randomized placebo-controlled 2-year study. Transplantation (2004) 0.85
Cardiovascular risk profile and risk stratification of the hypertensive population attended by general practitioners and specialists in Spain. The CONTROLRISK study. J Hum Hypertens (2007) 0.85
Influence of diabetes and type of hypertension on response to antihypertensive treatment. Hypertension (2000) 0.85
Are renal hemodynamics a key factor in the development and maintenance of arterial hypertension in humans? Hypertension (1994) 0.84
[Evaluation and validation of Omron Hem 705 CP and Hem 706/711 monitors for self-measurement of blood pressure]. Aten Primaria (2000) 0.84
Atorvastatin prevents glomerulosclerosis and renal endothelial dysfunction in hypercholesterolaemic rabbits. Nephrol Dial Transplant (2001) 0.84
Losartan reduces phenylephrine constrictor response in aortic rings from spontaneously hypertensive rats. Role of nitric oxide and angiotensin II type 2 receptors. Hypertension (1996) 0.84
Ovarian endometriosis and clear cell carcinoma, leiomyomatosis peritonealis disseminata, and endometrial adenocarcinoma: an unusual, pathogenetically related association. Int J Gynecol Pathol (2001) 0.84
Fibrosing cholestatic hepatitis in hepatitis C virus-infected renal transplant recipients. J Am Soc Nephrol (1998) 0.83
Antihypertensive treatment efficacy in type II diabetes mellitus. Dissociation between casual and 24-hour ambulatory blood pressure. Spanish Multicenter Study Group. Hypertension (1995) 0.83
Points to consider in the development of seed stocks of pluripotent stem cells for clinical applications: International Stem Cell Banking Initiative (ISCBI). Regen Med (2015) 0.83
Participation of nitric oxide in the regulation of renal function: possible role in the genesis of arterial hypertension. J Hypertens (1994) 0.83
Determining the trough-to-peak ratio in parallel-group trials. Systolic Hypertension in Europe (SYST-EUR) Trial Investigators. Hypertension (1997) 0.83
AT(1) receptor antagonism reduces endothelial dysfunction and intimal thickening in atherosclerotic rabbits. Hypertension (1999) 0.83
Association of thin basement membrane nephropathy with hypercalciuria, hyperuricosuria and nephrolithiasis. Kidney Int (1998) 0.83
[Influencing factors in the control of phosphorus in peritoneal dialysis. Therapeutic options]. Nefrologia (2000) 0.82
Effect of atorvastatin on endothelium-dependent constrictor factors in dyslipidemic rabbits. Gen Pharmacol (2000) 0.82
Salt sensitivity: concept and pathogenesis. Diabetes Res Clin Pract (1998) 0.82
Angiotensinogen and blood pressure among blacks: findings from a community survey in Jamaica. J Hypertens (1996) 0.82
Peritoneal resting is beneficial in peritoneal hyperpermeability and ultrafiltration failure. Adv Perit Dial (1993) 0.82
Interference by ranitidine with aldosterone secretion in vivo. Eur J Clin Pharmacol (1984) 0.82
Renal and vascular consequences of the chronic nitric oxide synthase inhibition. Effects of antihypertensive drugs. Am J Hypertens (1996) 0.82
Renal effects of fenoldopam in refractory hypertension. J Hypertens (1988) 0.82
[Lymphomatoid granulomatosis with early skin involvement. Clinico-pathological study of a case]. Sangre (Barc) (1987) 0.81
Effects of different dose levels and vaccination schedules on immune response to a recombinant DNA hepatitis B vaccine in haemodialysis patients. Vaccine (1990) 0.81
Exogenous cGMP prevents decrease in diuresis and natriuresis induced by inhibition of NO synthesis. Am J Physiol (1993) 0.81
Update on organ donation and retrieval in Spain. Nephrol Dial Transplant (1999) 0.81
Fusocellular gonadal stromal tumour of the testis with epithelial and myoid differentiation. Histopathology (1996) 0.81
[Clinical and biochemical characteristics of predialysis patients in terms of 25 hydroxy vitamin D levels]. Nefrologia (2011) 0.81
Interpreting treatment-induced blood pressure reductions measured by ambulatory blood pressure monitoring. J Hum Hypertens (2013) 0.81
Long-term influences of antihypertensive therapy on microalbuminuria in essential hypertension. Kidney Int Suppl (1994) 0.81